Article Details

FDA Approves Merilog, First Rapid-Acting Insulin Biosimilar for Diabetes

Retrieved on: 2025-02-14 21:24:03

Tags for this article:

Click the tags to see associated articles and topics

FDA Approves Merilog, First Rapid-Acting Insulin Biosimilar for Diabetes. View article details on hiswai:

Excerpt

“The FDA has now approved three biosimilar insulin products to treat diabetes,” said Peter Stein, MD, director of the Office of New Drugs in the FDA's ...

Article found on: www.patientcareonline.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up